Merkel Cell CarcinomaSymptoms, Doctors, Treatments, Advances & More
Merkel Cell Carcinoma Overview
Learn About Merkel Cell Carcinoma
- Merkel cell carcinoma
- Carcinoma, merkel cell
- Cutaneous neuroendocrine carcinoma
- Merkel cell cancer
- Merkle tumors
Rachel Loschiavo PA-C
Paul Nghiem is a Dermatologist practicing medicine in Seattle, Washington. Dr. Nghiem is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Eccrine Porocarcinoma, and Melanoma.
Manisha Thakuria is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Thakuria is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Actinic Keratosis, Warts, and Granuloma Annulare. Dr. Thakuria is board certified in Dermatology.
Swedish Cancer Institute Medical Oncology - Edmonds
"Dr. Paulson is passionate about practicing medical oncology, as it seamlessly integrates cutting-edge scientific advancements with the compassionate essence of medicine. Her clinical interests focus on skin cancer and solid tumor immunotherapy while Dr. Paulson’s appreciation lies in the ability to establish meaningful connections with patients and their families, throughout their care. Dr. Paulson firmly believes that optimal cancer care is achieved through a collaborative, team-based approach and takes great joy in working alongside an interdisciplinary team of dedicated healthcare professionals. Recognizing the pivotal role of patients in their own care, she is committed to transparent communication, ensuring that everyone understands the ""how and why"" behind their personalized treatment plans. In addition to her clinical role, Dr. Paulson is a skilled clinical researcher, serving as the Principal Investigator for various clinical trials aimed at bringing the latest advancements in cancer care and the lead for the Center for Immuno-Oncology at the Paul G Allen Research Center. Furthermore, she is dedicated to nurturing the next generation of medical professionals, actively supporting medical students at the Washington State University Elson E. Floyd Medical School in Everett, particularly in advancing their understanding of emerging immunotherapies. In 2023, Dr. Kelly Paulson was honored as the inaugural recipient of the Jeff Ward Award, established to memorialize him. This distinguished award acknowledges medical staff members who contribute positively to the Edmonds community through exceptional leadership, mentorship, or improvements in patient care. Also, she is a 2024 Castle Connolly Top Doctor. Dr. Paulson sees patients at the Edmonds and First Hill Swedish Cancer Institute locations.". Dr. Paulson is rated as an Elite provider by MediFind in the treatment of Merkel Cell Carcinoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Neuroendocrine Tumor, Small Cell Lung Cancer (SCLC), and Colorectal Cancer. Dr. Paulson is board certified in American Board Of Internal Medicine. Dr. Paulson is currently accepting new patients.
Summary: Researchers are looking for new ways to treat people with solid tumors, lymphomas (blood cancers), and a certain type of skin cancer. The goals of this study are to learn: * About the safety of pembrolizumab (the study medicine) and if people tolerate it * What happens to different doses of pembrolizumab in a person's body over time * How the cancer responds (gets smaller or goes away) to treatmen...
Summary: This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be removed by surgery (unresectable) or that has spread from where it first started to other places in the body (metastatic) in kidney transplant recipients. Immunotherapy with nivolumab and ipilimumab, may induce changes in body's immune syst...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center


